Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
FDA Orange Book
0
Canada
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Beta Subunit Hcg (123-145)
2. Hcg-beta (123-145)
1. Hcg-beta (123-145)
2. Beta-subunit Hcg (123-145)
3. 66053-67-6
4. Beta Subunit Hcg (123-145)
5. L-glutamine, L-alanyl-l-prolyl-l-prolyl-l-prolyl-l-seryl-l-leucyl-l-prolyl-l-seryl-l-prolyl-l-seryl-l-arginyl-l-leucyl-l-prolylglycyl-l-prolyl-l-seryl-l-alpha-aspartyl-l-threonyl-l-prolyl-l-isoleucyl-l-leucyl-l-prolyl-
| Molecular Weight | 2321.6 g/mol |
|---|---|
| Molecular Formula | C105H169N27O32 |
| XLogP3 | -8.6 |
| Hydrogen Bond Donor Count | 25 |
| Hydrogen Bond Acceptor Count | 34 |
| Rotatable Bond Count | 59 |
| Exact Mass | 2321.2460512 g/mol |
| Monoisotopic Mass | 2320.2426963 g/mol |
| Topological Polar Surface Area | 868 Ų |
| Heavy Atom Count | 164 |
| Formal Charge | 0 |
| Complexity | 5430 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 24 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
NDC Package Code : 60870-0315
Start Marketing Date : 1980-04-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 76403-3002
Start Marketing Date : 2016-04-27
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (2000000[iU]/2000000[iU])
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 76403-3010
Start Marketing Date : 2015-07-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (10000000[iU]/10000000[iU])
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 76403-3001
Start Marketing Date : 2015-07-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1000000[iU]/1000000[iU])
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 76403-3005
Start Marketing Date : 2015-07-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (5000000[iU]/5000000[iU])
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 76403-3105
Start Marketing Date : 2021-11-22
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (5000000[iU]/5000000[iU])
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 71052-631
Start Marketing Date : 2020-10-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (0.005U/.005U)
Marketing Category : BULK INGREDIENT

NDC Package Code : 42205-0523
Start Marketing Date : 2015-08-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1[iU]/[iU])
Marketing Category : BULK INGREDIENT FOR HUMAN P...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]VMF Number : 5912
Submission : 2007-11-13
Status : Active
Type : II
VMF Number : 5789
Submission : 2003-12-03
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
About the Company : Aspen API is the cooperative entity formed by Aspen Oss in the Netherlands and Fine Chemicals Corporation in South Africa. With quality, compliance, and teamwork at its core, Aspen...
About the Company : The year 1969, was a momentous beginning for the pharmaceutical industry in India. Around four decades ago, the first Indo-Japanese venture was inked and a new entity known as Uni-...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Human Chorionic Gonadotropin is a Protein drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Infertility.
Lead Product(s): Human Chorionic Gonadotropin,Inapplicable
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Protein
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 04, 2025

Lead Product(s) : Human Chorionic Gonadotropin,Inapplicable
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
The Role of hCG in Thawed Embryo Transfer
Details : Human Chorionic Gonadotropin is a Protein drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Infertility.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
June 04, 2025

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
GenSci094 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Infertility.
Lead Product(s): GenSci094,Follitropin Alfa,Ganirelix,Human Chorionic Gonadotropin,Progesterone
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Undisclosed
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 19, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : GenSci094,Follitropin Alfa,Ganirelix,Human Chorionic Gonadotropin,Progesterone
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Sixth Affiliated Hospital, Sun Yat-sen University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : GenSci094 is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Infertility.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 19, 2023

Details:
Human Chorionic Gonadotrophin is a Hormone drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infertility, Female.
Lead Product(s): Human Chorionic Gonadotropin,Inapplicable
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Hormone
Sponsor: EIPICO
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 27, 2020

Lead Product(s) : Human Chorionic Gonadotropin,Inapplicable
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : EIPICO
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Human Chorionic Gonadotrophin is a Hormone drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Infertility, Female.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
October 27, 2020

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Approved
Registration Country : Sweden
Chorionic Gonadotrophin (Human, urine-derived)
Brand Name : Gonasi Set
Dosage Form : Solution For Injection
Dosage Strength : 5000IE
Packaging :
Approval Date : 19/07/2021
Application Number : 20191030000093
Regulatory Info : Approved
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Chorionic Gonadotrophin (Human, urine-derived)
Brand Name : Pregnyl
Dosage Form : Solution For Injection
Dosage Strength : 1500IU
Packaging :
Approval Date : 05/05/1958
Application Number : 19580505000012
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Deregistered
Registration Country : Sweden
Chorionic Gonadotrophin (Human, urine-derived)
Brand Name : Pregnyl
Dosage Form : Solution For Injection
Dosage Strength : 5000IE
Packaging :
Approval Date : 31/01/1986
Application Number : 19860131000083
Regulatory Info : Deregistered
Registration Country : Sweden

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Italy
Brand Name : Ovitrelle
Dosage Form : Choriogonadotropin Alfa 250Mcg/0,5Ml 1 Unit Parenteral Use
Dosage Strength : 1 pen 250 mcg 0.5 ml + 1 needle
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Choriomon 5000 I.E
Dosage Form :
Dosage Strength :
Packaging : 3
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Brevactid 1500 I.E
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Australia
Brand Name : Brevactid 1500 I.E
Dosage Form :
Dosage Strength :
Packaging : 1
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral
Grade : Topical, Parenteral
Category : Parenteral, Topical
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Parenteral, Thickeners and Stabilizers
Brand Name : Citric Acid Monohydrate
Application : Parenteral, Thickeners and Stabilizers
Excipient Details : Used as a pH regulator and preservative in many Biological formulations and cell culture media. Also it can be used as a chelating agent.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Citric Acid Excipient
Dosage Form : Cream / Lotion / Ointment, Emulsion, Injectable / Parenteral, Softgels, Tablet
Grade : Oral, Topical, Parenteral
Category : Film Formers & Plasticizers, Parenteral, Topical
Brand Name : Glycerol Multi-Compendial
Application : Parenteral
Excipient Details : A & C's Glycerol multi-compendial is an excipient that meets USP-NF, EP and BP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Not Available
Ingredient(s) : Glycerol Excipient
Application : Parenteral
Excipient Details : A & C's Glycerol is an excipient which meets the USP monograph.
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
53
PharmaCompass offers a list of Human Chorionic Gonadotropin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Human Chorionic Gonadotropin manufacturer or Human Chorionic Gonadotropin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Human Chorionic Gonadotropin manufacturer or Human Chorionic Gonadotropin supplier.
PharmaCompass also assists you with knowing the Human Chorionic Gonadotropin API Price utilized in the formulation of products. Human Chorionic Gonadotropin API Price is not always fixed or binding as the Human Chorionic Gonadotropin Price is obtained through a variety of data sources. The Human Chorionic Gonadotropin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Human Chorionic Gonadotropin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Human Chorionic Gonadotropin, including repackagers and relabelers. The FDA regulates Human Chorionic Gonadotropin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Human Chorionic Gonadotropin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Human Chorionic Gonadotropin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Human Chorionic Gonadotropin supplier is an individual or a company that provides Human Chorionic Gonadotropin active pharmaceutical ingredient (API) or Human Chorionic Gonadotropin finished formulations upon request. The Human Chorionic Gonadotropin suppliers may include Human Chorionic Gonadotropin API manufacturers, exporters, distributors and traders.
click here to find a list of Human Chorionic Gonadotropin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Human Chorionic Gonadotropin DMF (Drug Master File) is a document detailing the whole manufacturing process of Human Chorionic Gonadotropin active pharmaceutical ingredient (API) in detail. Different forms of Human Chorionic Gonadotropin DMFs exist exist since differing nations have different regulations, such as Human Chorionic Gonadotropin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Human Chorionic Gonadotropin DMF submitted to regulatory agencies in the US is known as a USDMF. Human Chorionic Gonadotropin USDMF includes data on Human Chorionic Gonadotropin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Human Chorionic Gonadotropin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Human Chorionic Gonadotropin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Human Chorionic Gonadotropin Drug Master File in Japan (Human Chorionic Gonadotropin JDMF) empowers Human Chorionic Gonadotropin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Human Chorionic Gonadotropin JDMF during the approval evaluation for pharmaceutical products. At the time of Human Chorionic Gonadotropin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Human Chorionic Gonadotropin suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Human Chorionic Gonadotropin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Human Chorionic Gonadotropin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Human Chorionic Gonadotropin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Human Chorionic Gonadotropin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Human Chorionic Gonadotropin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Human Chorionic Gonadotropin suppliers with NDC on PharmaCompass.
Human Chorionic Gonadotropin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Human Chorionic Gonadotropin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Human Chorionic Gonadotropin GMP manufacturer or Human Chorionic Gonadotropin GMP API supplier for your needs.
A Human Chorionic Gonadotropin CoA (Certificate of Analysis) is a formal document that attests to Human Chorionic Gonadotropin's compliance with Human Chorionic Gonadotropin specifications and serves as a tool for batch-level quality control.
Human Chorionic Gonadotropin CoA mostly includes findings from lab analyses of a specific batch. For each Human Chorionic Gonadotropin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Human Chorionic Gonadotropin may be tested according to a variety of international standards, such as European Pharmacopoeia (Human Chorionic Gonadotropin EP), Human Chorionic Gonadotropin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Human Chorionic Gonadotropin USP).